Biosyent Inc BIOYF

Primary Symbol: V.RX

Healthcare

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.

TSXV:RX - Post by User

Biosyent Inc > Jason Del Vicario- BNN - Buy

<< Previous

Bullboard Posts

Next >>

Comment by retiredcfon Oct 04, 2022 7:03am

172 Views

Post# 35003364

RE:Jason Del Vicario- BNN - Buy

Was surprised at yesterday's decline given that it was such a strong day in the market and following these positive comments. It doesn't mean much as trading volume was low and 80% of it came at 2 pm. The final drop from $7.51 to $7.34 was near the close and for only 200 shares. GLTA

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec